These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 28847738)
1. Sorsby fundus dystrophy - A review of pathology and disease mechanisms. Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738 [TBL] [Abstract][Full Text] [Related]
2. In vitro stem cell modelling demonstrates a proof-of-concept for excess functional mutant TIMP3 as the cause of Sorsby fundus dystrophy. Hongisto H; Dewing JM; Christensen DR; Scott J; Cree AJ; Nättinen J; Määttä J; Jylhä A; Aapola U; Uusitalo H; Kaarniranta K; Ratnayaka JA; Skottman H; Lotery AJ J Pathol; 2020 Oct; 252(2):138-150. PubMed ID: 32666594 [TBL] [Abstract][Full Text] [Related]
3. Molecular dissection of TIMP3 mutation S156C associated with Sorsby fundus dystrophy. Fogarasi M; Janssen A; Weber BH; Stöhr H Matrix Biol; 2008 Jun; 27(5):381-92. PubMed ID: 18295466 [TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix dysfunction in Sorsby patient-derived retinal pigment epithelium. Engel AL; Wang Y; Khuu TH; Worrall E; Manson MA; Lim RR; Knight K; Yanagida A; Qi JH; Ramakrishnan A; Weleber RG; Klein ML; Wilson DJ; Anand-Apte B; Hurley JB; Du J; Chao JR Exp Eye Res; 2022 Feb; 215():108899. PubMed ID: 34929159 [TBL] [Abstract][Full Text] [Related]
5. Sorsby fundus dystrophy: Insights from the past and looking to the future. Anand-Apte B; Chao JR; Singh R; Stöhr H J Neurosci Res; 2019 Jan; 97(1):88-97. PubMed ID: 30129971 [TBL] [Abstract][Full Text] [Related]
6. Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis. Soboleva G; Geis B; Schrewe H; Weber BH J Cell Physiol; 2003 Oct; 197(1):149-56. PubMed ID: 12942551 [TBL] [Abstract][Full Text] [Related]
7. A mouse model for Sorsby fundus dystrophy. Weber BH; Lin B; White K; Kohler K; Soboleva G; Herterich S; Seeliger MW; Jaissle GB; Grimm C; Reme C; Wenzel A; Asan E; Schrewe H Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2732-40. PubMed ID: 12147610 [TBL] [Abstract][Full Text] [Related]
8. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Fariss RN; Apte SS; Luthert PJ; Bird AC; Milam AH Br J Ophthalmol; 1998 Nov; 82(11):1329-34. PubMed ID: 9924344 [TBL] [Abstract][Full Text] [Related]
9. The retinal pigment epithelium in Sorsby Fundus Dystrophy shows increased sensitivity to oxidative stress-induced degeneration. Wolk A; Upadhyay M; Ali M; Suh J; Stoehr H; Bonilha VL; Anand-Apte B Redox Biol; 2020 Oct; 37():101681. PubMed ID: 32828705 [TBL] [Abstract][Full Text] [Related]
10. Drusen in patient-derived hiPSC-RPE models of macular dystrophies. Galloway CA; Dalvi S; Hung SSC; MacDonald LA; Latchney LR; Wong RCB; Guymer RH; Mackey DA; Williams DS; Chung MM; Gamm DM; Pébay A; Hewitt AW; Singh R Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8214-E8223. PubMed ID: 28878022 [TBL] [Abstract][Full Text] [Related]
11. Deglycosylation Increases the Aggregation and Angiogenic Properties of Mutant Tissue Inhibitor of Metalloproteinase 3 Protein: Implications for Sorsby Fundus Dystrophy. Qi JH; Anand-Apte B Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430707 [TBL] [Abstract][Full Text] [Related]
12. Tissue Inhibitor of Metalloproteinase 3 (TIMP3) mutations increase glycolytic activity and dysregulate glutamine metabolism in RPE cells. Grenell A; Singh C; Raju M; Wolk A; Dalvi S; Jang GF; Crabb JS; Hershberger CE; Manian KV; Hernandez K; Crabb JW; Singh R; Du J; Anand-Apte B Mol Metab; 2024 Oct; 88():101995. PubMed ID: 39047907 [TBL] [Abstract][Full Text] [Related]
13. Role of FGF and Hyaluronan in Choroidal Neovascularization in Sorsby Fundus Dystrophy. Wolk A; Hatipoglu D; Cutler A; Ali M; Bell L; Hua Qi J; Singh R; Batoki J; Karle L; Bonilha VL; Wessely O; Stoehr H; Hascall V; Anand-Apte B Cells; 2020 Mar; 9(3):. PubMed ID: 32143276 [TBL] [Abstract][Full Text] [Related]
14. Sorsby Fundus Dystrophy Mutation in Tissue Inhibitor of Metalloproteinase 3 (TIMP3) promotes Choroidal Neovascularization via a Fibroblast Growth Factor-dependent Mechanism. Qi JH; Bell B; Singh R; Batoki J; Wolk A; Cutler A; Prayson N; Ali M; Stoehr H; Anand-Apte B Sci Rep; 2019 Nov; 9(1):17429. PubMed ID: 31757977 [TBL] [Abstract][Full Text] [Related]
17. Reticular Pseudodrusen in Sorsby Fundus Dystrophy. Gliem M; Müller PL; Mangold E; Bolz HJ; Stöhr H; Weber BH; Holz FG; Charbel Issa P Ophthalmology; 2015 Aug; 122(8):1555-62. PubMed ID: 26077580 [TBL] [Abstract][Full Text] [Related]
18. Sorsby Fundus Dystrophy: Novel Mutations, Novel Phenotypic Characteristics, and Treatment Outcomes. Gliem M; Müller PL; Mangold E; Holz FG; Bolz HJ; Stöhr H; Weber BH; Charbel Issa P Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2664-76. PubMed ID: 25766588 [TBL] [Abstract][Full Text] [Related]
19. Quantifying the Separation Between the Retinal Pigment Epithelium and Bruch's Membrane using Optical Coherence Tomography in Patients with Inherited Macular Degeneration. Khan KN; Borooah S; Lando L; Dans K; Mahroo OA; Meshi A; Kalitzeos A; Agorogiannis G; Moghimi S; Freeman WR; Webster AR; Moore AT; McKibbin M; Michaelides M Transl Vis Sci Technol; 2020 May; 9(6):26. PubMed ID: 32821523 [TBL] [Abstract][Full Text] [Related]
20. Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy. Saihan Z; Li Z; Rice J; Rana NA; Ramsden S; Schlottmann PG; Jenkins SA; Blyth C; Black GC; McKie N; Webster AR Mol Vis; 2009 Jun; 15():1218-30. PubMed ID: 19536307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]